IL2RA and cancer: Importantly, the BF BSH-accelerated CRC progression was ameliorated by anti-CCL28 or anti-CD25 antibody treatment, which mainly resulted from enhanced cancer cell apoptosis (Fig. 7g–n and Supplementary Fig. 6k).